Document is current
Any future updates will be listed below
-
Authors
Bravo-Hernandez, Mariana https://orcid.org/0000-0001-8762-0357
Tadokoro, Takahiro https://orcid.org/0000-0003-4884-0247
Navarro, Michael R.
Platoshyn, Oleksandr
Kobayashi, Yoshiomi
Marsala, Silvia
Miyanohara, Atsushi
Juhas, Stefan
Juhasova, Jana
Skalnikova, Helena https://orcid.org/0000-0003-0591-5018
Tomori, Zoltan https://orcid.org/0000-0002-0685-0247
Vanicky, Ivo
Studenovska, Hana https://orcid.org/0000-0001-7917-1790
Proks, Vladimir https://orcid.org/0000-0001-7368-7120
Chen, PeiXi https://orcid.org/0000-0002-7584-4609
Govea-Perez, Noe
Ditsworth, Dara
Ciacci, Joseph D.
Gao, Shang
Zhu, Wenlian
Ahrens, Eric T.
Driscoll, Shawn P.
Glenn, Thomas D.
McAlonis-Downes, Melissa
Da Cruz, Sandrine
Pfaff, Samuel L.
Kaspar, Brian K.
Cleveland, Don W. https://orcid.org/0000-0002-1934-3682
Marsala, Martin https://orcid.org/0000-0001-5048-6422
- License Information
-
More Information
Article History
Received: 19 December 2018
Accepted: 30 October 2019
First Online: 23 December 2019
Competing interests
: M. Marsala is the scientific founder of Neurgain Technologies, Inc. and has an equity interest in the company. In addition, he serves as a consultant to Neurgain Technologies, Inc., and receives compensation for these services. The terms of this arrangement have been reviewed and approved by the University of California San Diego in accordance with its policies on conflict of interests. B.K.K. is a Chief Scientific Officer in Avexis Inc. All other authors declare that no competing interests exist.
